Format

Send to

Choose Destination
Semin Thorac Cardiovasc Surg. 2013 Summer;25(2):97-9. doi: 10.1053/j.semtcvs.2013.07.007.

Coronary artery bypass graft surgery remains the standard of care for patients with diabetes.

Author information

1
Department of Cardiothoracic Surgery, Emory University school of Medicine, Atlanta, Georgia.

Abstract

Coronary artery bypass graft surgery (CABG) and percutaneous coronary intervention (PCI) are proven effective treatments of coronary artery disease (CAD), however, the optimal revascularization strategy remains unclear in certain patient subsets. The recently published "Future Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multivessel Disease (FREEDOM)" trial is a randomized study evaluating the use of CABG vs PCI in diabetic patients with multivessel coronary disease. The purpose of this editorial is to review the FREEDOM trial and the available literature guiding clinicians to make evidence-based decisions when treating diabetic patients with multivessel coronary disease. The current evidence suggests that CABG should remain the standard of care for this patient population.

KEYWORDS:

CABG; Coronary artery disease; Diabetes; PCI

PMID:
24216525
DOI:
10.1053/j.semtcvs.2013.07.007
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center